Sign in
Join
Home
News
Innovation That Matters
WuXi News
Events
Newsletter
Contact
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Wednesday, September 18, 2019
Sign in / Join
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
WuXi XPress: for WuXi news and R&D insights
Home
News
Innovation That Matters
WuXi News
Events
Events
WuXi AppTec’s Enabling Capability Recognized by Partners and Philadelphia Authority at…
Events
The New Healthcare Ecosystem | WuXi Healthcare Forum
Events
Medicines for the Global Impact | WuXi Healthcare Forum
Events
Announcing Latest Agenda for WuXi Healthcare Forum 2019
Events
Announcing Distinguished Speakers for WuXi Healthcare Forum 2019
Newsletter
Contact
18th September 2019
R&D INSIGHTS – SCIENCE FRONTIERS
WuXi NEWS
Innovation That Matters
Redefining Therapeutics Through Control of Gene Expression, a Conversation with Nancy Simonian, M.D., President and CEO, Syros Pharmaceuticals
September 11, 2019
Innovation That Matters
Kymera’s Next Generation Therapeutics: Protein Degraders. New Way and New Rules for a New Modality.
Innovation That Matters
Pioneering Gut Science, Kintai Therapeutics Is Bringing a New Small Molecule Modality to Fruition
Innovation That Matters
Leading the Charge in the Fight Against Cancer: Laurie Glimcher, M.D., President and CEO, Dana Farber Cancer Institute
INNOVATION THAT MATTERS
Innovation That Matters
Redefining Therapeutics Through Control of Gene Expression, a Conversation with Nancy...
September 11, 2019
Innovation That Matters
Kymera’s Next Generation Therapeutics: Protein Degraders. New Way and New Rules...
September 10, 2019
Innovation That Matters
Pioneering Gut Science, Kintai Therapeutics Is Bringing a New Small Molecule...
September 10, 2019
Innovation That Matters
Leading the Charge in the Fight Against Cancer: Laurie Glimcher, M.D.,...
September 5, 2019
Innovation That Matters
The Quest for Anti-Fibrotic Therapies Leads to Blade Therapeutics
September 2, 2019
Innovation That Matters
OSE Immunotherapeutics Developing Tedopi® to Jump-Start Cytotoxic T-cell Response in...
August 26, 2019
MEDIA CONTENT
EDITORS NEWS CHOICE
Redefining Therapeutics Through Control of Gene Expression, a Conversation with Nancy Simonian, M.D., President...
September 11, 2019
Kymera’s Next Generation Therapeutics: Protein Degraders. New Way and New Rules for a New...
September 10, 2019
Pioneering Gut Science, Kintai Therapeutics Is Bringing a New Small Molecule Modality to Fruition
September 10, 2019
Leading the Charge in the Fight Against Cancer: Laurie Glimcher, M.D., President and CEO,...
September 5, 2019
PUBLISHED TODAY
[Articles] Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
Published on 2019-09-18
By David R Matthews, Päivi M Paldánius, Pieter Proot, YannTong Chiang, Michael Stumvoll, Stefano Del Prato, VERIFY study group
[Comment] VERIFY the role of initial combination therapy in patients with type 2 diabetes
Published on 2019-09-18
By Ofri Mosenzon, Gil Leibowitz
[Correspondence] A perfect storm in the Caribbean requires a concerted response
Published on 2019-09-17
By Sandeep Maharaj, Terence Seemungal, Martin McKee
Study on DNA spread by genetically modified mosquitoes prompts backlash
Published on 2019-09-17
By Alex
Older posts
WuXi NEWS
WuXi AppTec Launches DNA Encoded Library (DEL) Service Package “DELight” to Expedite Early Drug...
September 3, 2019
WuXi AppTec Reports First Half 2019 Interim Results
August 19, 2019
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
July 22, 2019
WuXi AppTec Named One of MIT Technology Review’s 50 Smartest Companies
July 12, 2019
WuXi XPRESS Vol. #001 – June 2019
June 27, 2019
WuXi AppTec’s Enabling Capability Recognized by Partners and Philadelphia Authority at BIO 2019
June 10, 2019
insitro’s Daphne Koller Discusses Machine Learning, Predictive Biology and Therapeutic Approaches for Nonalcoholic Steatohepatitis...
May 20, 2019
STORM Therapeutics Pioneering New RNA Pathways to Novel Therapies
May 17, 2019
EVENTS
WuXi AppTec’s Enabling Capability Recognized by Partners and Philadelphia Authority at BIO 2019
Events
June 10, 2019
The New Healthcare Ecosystem | WuXi Healthcare Forum
Events
March 18, 2019
Medicines for the Global Impact | WuXi Healthcare Forum
Events
March 18, 2019
Announcing Latest Agenda for WuXi Healthcare Forum 2019
Events
February 20, 2019
Edit with Live CSS
